Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$821K Sell
261,463
-17,774
-6% -$55.6K 0.01% 1224
2026
Q1
$815K Buy
279,237
+86,363
+45% +$247K 0.01% 1175
2025
Q4
$476K Buy
192,874
+60,123
+45% +$143K 0.01% 1482
2025
Q3
$296K Buy
132,751
+29,358
+28% +$67.2K ﹤0.01% 1727
2025
Q2
$249K Buy
103,393
+33,993
+49% +$82.7K ﹤0.01% 1803
2025
Q1
$162K Buy
69,400
+7,763
+13% +$15.5K ﹤0.01% 1848
2024
Q4
$114K Sell
61,637
-152,928
-71% -$338K ﹤0.01% 1828
2024
Q3
$524K Buy
214,565
+98,162
+84% +$220K 0.01% 1295
2024
Q2
$239K Buy
+116,403
New +$265K ﹤0.01% 1724
2022
Q2
– Sell
-417,408
Closed -$1.35M – 748
2022
Q1
$1.35M Sell
417,408
-28,678
-6% -$80.1K 0.02% 718
2021
Q4
$1.25M Sell
446,086
-26,965
-6% -$77.3K 0.02% 742
2021
Q3
$1.31M Buy
473,051
+30,574
+7% +$96.8K 0.02% 688
2021
Q2
$1.52M Buy
442,477
+47,112
+12% +$153K 0.03% 610
2021
Q1
$1.08M Buy
+395,365
New +$1.12M 0.02% 674
2020
Q2
– Sell
-61,768
Closed -$142K – 513
2020
Q1
$142K Buy
61,768
+81
+0.1% +$293 0.01% 544
2019
Q4
$287K Buy
+61,687
New +$274K 0.01% 992
2019
Q3
– Sell
-18,985
Closed -$91K – 852
2019
Q2
$91K Buy
+18,985
New +$85.1K ﹤0.01% 944
2019
Q1
– Sell
-35,270
Closed -$138K – 921
2018
Q4
$138K Buy
35,270
+20,196
+134% +$86.2K 0.01% 845
2018
Q3
$70K Buy
15,074
+3,531
+31% +$16.8K ﹤0.01% 966
2018
Q2
$53K Buy
+11,543
New +$67.8K ﹤0.01% 946

Other funds holding ABEV

Atria Investments's ABEV Position: Q2 2026 in Review

Atria Investments reduced its Ambev (ABEV) stake by 6.4% in Q2 2026, selling an estimated $55.6K and leaving 261,463 shares worth $821K. The position accounts for 0.01% of the portfolio, ranked #1224.

Atria Investments first reported a position in ABEV in Q2 2018 and has held it in 20 quarters since. The position peaked at $1.52M in Q2 2021. 404 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Atria Investments held 261,463 shares of Ambev worth $821K as of Q2 2026.
  • Atria Investments sold 17,774 Ambev shares in Q2 2026, an estimated $55.6K.
  • Ambev made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1224 holding.
  • Atria Investments first reported a position in Ambev in Q2 2018 and has held it in 20 quarters since.
  • Atria Investments's Ambev position peaked at $1.52M in Q2 2021.
  • 404 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.